概述

脊索瘤是一种罕见的骨癌,最初表现为脊柱或颅骨骨骼内细胞异常增殖形成的生长物。通常在脊柱上方的颅骨(颅底)或脊柱底部(骶骨)形成。

脊索瘤始发于出生前帮助形成脊柱的细胞。这些细胞通常会变成脊柱的椎间盘。如果这些细胞在婴儿出生时仍有残留,残留细胞通常会在婴儿出生后不久消失。但其中少数细胞有时会保留下来,并在罕见情况下会发展成癌细胞。

脊索瘤通常生长缓慢。脊索瘤可能很难治疗,因其在非常靠近脊髓和其他重要结构处生长,如动脉、神经或脑。,这种癌症通常会在治疗后复发。

Types

Different types of chordomas include:

  • Conventional chordoma, also called classic chordoma and classical chordoma. This is the most common type. Under a microscope, it looks like bubbly cells in a slimy mix, similar to soap bubbles.
  • Chondroid chordoma. Up to roughly 15% of chordomas are this type. Under a microscope, chondroid chordomas look similar to classic chordomas. But they also have tissue that looks similar to cartilage tissue found in parts of the body such as the nose.
  • Dedifferentiated. Up to just under 10% of chordomas are this type. Under a microscope, this type of chordoma has two parts. One part looks like classic chordoma cells that also have a special protein called brachyury. The other part looks like a different type of cancer cell.
  • Poorly differentiated. This rare type of chordoma mostly affects kids and young adults and is usually found in the skull base. It's identified due to a missing gene called SMARCB1 (INI1).

症状

脊索瘤的体征和症状可能包括:

  • 头痛。
  • 颈部疼痛。
  • 视力问题,包括视力模糊、复视或视力丧失。
  • 平衡问题。
  • 听力减退。
  • 面神经麻痹。
  • 肌无力。
  • 吞咽困难。
  • 气短。

Skull base chordoma symptoms

The first signs and symptoms of a clival bone chordoma or a skull base chordoma may include:

  • Headache.
  • Facial numbness, weakness, drooping or paralysis.
  • Vision trouble, including blurred or double vision or, sometimes, vision loss.

Other possible symptoms include:

  • Hearing loss.
  • Hoarseness.
  • Trouble speaking as usual.
  • Trouble swallowing.

Middle spine, also called mobile spine, chordoma symptoms

The first signs and symptoms of a chordoma in the part of the spine between the skull base and the sacrum may include:

  • Arm or leg numbness or weakness.
  • Back pain that may spread to the buttocks and legs.
  • Breathing trouble.
  • Headache.
  • Neck stiffness or pain.
  • Neck pain that may spread to the shoulders.
  • Swallowing trouble.
  • Walking trouble.

Bottom of the spine, also called sacral, chordoma symptoms

The first signs and symptoms of a sacral chordoma may include:

  • Constipation.
  • Lump at the site of the tumor.
  • Numbness or tingling in the buttocks and inner thighs.
  • Muscle weakness.
  • Pain in the back, buttocks, pelvis or tailbone that may be worse when sitting.
  • Sudden urge to urinate that's hard to control.

Because chordomas grow very slowly and have general symptoms caused by many things, it's common not to notice signs and symptoms for years.

何时就医

如有任何症状令您担心,请与医生或其他医疗护理专业人员约诊。

病因

大多数脊索瘤的病因尚不明确。这种癌症通常始发于颅骨或脊柱的骨骼。

骨骼中细胞的 DNA 发生变化时就会出现脊索瘤。细胞的 DNA 含有指示细胞工作的指令。在健康细胞中,DNA 会发出指令让细胞以一定的速度生长和繁殖。这些指令会指示细胞在设定的时间死亡。而在癌细胞中,DNA 的变化给出了不同的指令。这些变化指示癌细胞快速生长和增殖。癌细胞会在健康细胞本应死亡时继续存活。这会导致细胞过多。

癌细胞形成一个肿块,称为肿瘤。肿瘤可能生长,侵入并破坏健康的机体组织。随着时间的推移,癌细胞可能会脱离原发病灶并扩散至身体其他部位。当癌症病灶扩散时,称为转移性癌。

风险因素

可能增加罹患脊索瘤的风险因素包括:

  • 年龄。 脊索瘤可能在任何年龄发生。不过这种癌症最常影响 40 到 60 岁的人群。
  • 家族史。 有脊索瘤家族史者可能有更高概率患病。

并发症

Complications of chordomas typically are caused by the tumors growing and pressing into blood vessels, nerves and other tissues. Other complications happen if the cancer spreads to other parts of the body.

Chordoma complications of the nervous system may include:

  • Cerebrospinal fluid leaks, though this is rare.
  • Headaches.
  • Hearing loss.
  • Problems with balance, coordination and walking.
  • Trouble swallowing or speaking.
  • Trouble breathing.
  • Vision problems.
  • Water buildup on the brain, which can increase pressure inside the skull and cause headaches, nausea and vomiting.
  • Weakness or numbness in the face, arms or legs.

Sometimes chordoma tumors can spread to other parts of the body. You may hear this called metastatic chordoma. Less than half of chordomas spread to other parts of the body. It's most common in chordomas that are found in areas of the spine below the neck and with the poorly differentiated type of chordoma. Sometimes metastatic chordoma may be called advanced chordoma or end-stage chordoma.

The most common place for a chordoma to spread is to the lungs. But it also can spread to the liver or other bones or soft tissues. Depending on where metastatic chordoma has spread, complications may include:

  • Bone breaks.
  • Extreme tiredness.
  • Lumps.
  • Pain.
  • Swelling of the belly.
  • Trouble breathing.
  • Yellow skin or eyes, called jaundice.
  • Weight loss.

Oct. 17, 2025

Living with 脊索瘤?

Connect with others like you for support and answers to your questions in the Sarcoma support group on Mayo Clinic Connect, a patient community.

Sarcoma Discussions

worriedgirl35
Possible liposarcoma?

14 Replies Fri, Oct 17, 2025

me67
Undifferentiated Pleomorphic Sarcoma: Anyone else want to share?

132 Replies Thu, Oct 16, 2025

Colleen Young, Connect Director
Diagnosed with sarcoma? Let's share

994 Replies Sat, Sep 27, 2025

See more discussions
  1. Elsevier Point of Care. Clinical Overview: Rare central nervous system tumors. https://www.clinicalkey.com. Accessed Nov. 20, 2024.
  2. Bone cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1418. Accessed Aug. 21, 2025.
  3. Winn HR, ed. Youmans and Winn Neurological Surgery. 8th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Nov. 20, 2024.
  4. Zenonos GA. Chordoma of the skull base. https://www.uptodate.com/contents/search. Accessed Aug. 21, 2025.
  5. Chordoma. National Cancer Institute. https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-bone-tumors/chordoma. Accessed Aug. 21, 2025.
  6. Barber SM, et al. Chordoma — Current understanding and modern treatment paradigms. Journal of Clinical Medicine. 2021; doi:10.3390/jcm10051054.
  7. Banks C, et al. ICAR: Endoscopic skull-base surgery. International Forum of Allergy & Rhinology. 2019; doi:10.1002/alr.22326.
  8. Stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). RadiologyInfo.org. https://www.radiologyinfo.org/en/info/stereotactic. Accessed Jan. 29, 2025.
  9. Dickerson TE, et al. Recurrent metastatic chordoma to the liver: A case report and review of the literature. Current Oncology. 2022; doi:10.3390/curroncol29070367.
  10. Song PH, et al. Symptom burden and life challenges reported by adult chordoma patients and their caregivers. Quality of Life Research. 2017; doi:10.1007/s11136-017-1544-2.
  11. Young VA, et al. Clinical study: Characteristics and patterns of metastatic disease from chordoma. Sarcoma. 2015; doi:10.1155/2015/517657.
  12. Alshammari J, et al. Clival chordoma with an atypical presentation: A case report. Journal of Medical Case Reports. 2012; doi:10.1186/1752-1947-6-410.
  13. Dudhe S, et al. Challenging the giant: A case report on a huge sacrococcygeal chordoma and its radiological insights. Radiology Case Reports. 2025; doi:10.1016/j.radcr.2024.10.157.
  14. Zhou Y, et al. The clinical outcomes for chordomas in the cranial base and spine: A single center experience. Medicine. 2019; doi:10.1097/MD.0000000000015980.
  15. Medical oncologic treatment of spinal malignancies and outcomes. Video. Mayo Clinic; 2023.
  16. Murphey MD, et al. Imaging of spinal chordoma and benign notochordal cell tumor (BNCT) with radiologic pathologic correlation. Skeletal Radiology. 2023; doi:10.1007/s00256-022-04158-7.
  17. Baig Mirza A, et al. Surgical management of spinal chordoma: A systematic review and single-center experience. World Neurosurgery. 2021; doi:10.1016/j.wneu.2021.09.001.
  18. Court C, et al. Management of chordoma of the sacrum and mobile spine. Orthopaedics & Traumatology: Surgery & Research. 2022; doi:10.1016/j.otsr.2021.103169.
  19. Goumenos S, et al. Clinical outcome after surgical treatment of sacral chordomas: A single-center retrospective cohort of 27 patients. Cancers. 2024; doi:10.3390/cancers16050973.
  20. Garofalo F, et al. The unresolved case of sacral chordoma: From misdiagnosis to challenging surgery and medical therapy resistance. Annals of Coloproctology. 2014; doi:10.3393/ac.2014.30.3.122.
  21. Zhang J, et al. Intradural cervical chordoma with diffuse spinal leptomeningeal spread: Case report and review of the literature. European Spine Journal. 2018; doi:10.1007/s00586-017-5443-6.
  22. Passeri T, et al. The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers. Journal of Neurosurgery. 2023; doi:10.3171/2023.1.JNS222180.
  23. Ma T, et al. Current understanding of brachyury in chordoma. BBA — Reviews on Cancer. 2023; doi:10.1016/j.bbcan.2023.189010.
  24. Elsamadicy AA, et al. The association of gender in the management and prognosis of vertebral and sacral chordoma: A SEER analysis. Journal of Clinical Medicine. 2025; doi:10.3390/jcm14051737.
  25. What is cancer? American Cancer Society. https://www.cancer.org/cancer/understanding-cancer/what-is-cancer.html. Accessed Aug. 31, 2025.
  26. Soule E, et al. Current management and image review of skull base chordoma: What the radiologist needs to know. 2021; doi:10.25259/JCIS_139_2021.
  27. CT scan. Mayo Clinic. https://www.mayoclinic.org/tests-procedures/ct-scan/about/pac-20393675. Accessed Sept. 4, 2025.
  28. American College of Surgeons. Bone cancer. In: AJCC Cancer Staging System. American College of Surgeons; 2025. https://online.statref.com. Accessed Sept. 8, 2025.
  29. Dastgheyb SS, et al. A prospective phase I/II clinical trial of high-dose proton therapy for chordomas and chondrosarcomas. Advances in Radiation Oncology. 2024; doi:10.1016/j.adro.2024.101456.
  30. Childhood chordoma treatment (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/types/bone/hp/child-chordoma-treatment-pdq. Accessed Sept. 9, 2025.
  31. Immunotherapy. American Cancer Society. https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy/immune-checkpoint-inhibitors.html. Accessed Sept. 18, 2025.
  32. Shyam Sunder S, et al. Adverse effects of tyrosine kinase inhibitors in cancer therapy: Pathophysiology, mechanisms and clinical management. Signal Transduction and Targeted Therapy. 2023; doi:10.1038/s41392-023-01469-6.
  33. Cancer survival rate: What it means for your prognosis. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/cancer/art-20044517. Accessed Sept. 18, 2025.
  34. Cancer survivors: Care for your body after treatment. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/cancer-survivor/art-20044015. Accessed Sept. 18, 2025.
  35. Stacchioti S, et al. Best practices for the management of local-regional recurrent chordoma: A position paper by the Chordoma Global Consensus Group. Annals of Oncology. 2017; doi:10.1093/annonc/mdx05.
  36. Bone cancer. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/bone-cancer/symptoms-causes/syc-20350217. Accessed Sept. 11, 2025.
  37. Steffner RJ, et al. Staging of bone and soft-tissue sarcomas. Journal of the American Academy of Orthopedic Surgeons. 2018; doi:10.5435/JAAOS-D-17-00055.
  38. Terminal cancer. National Cancer Institute. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/terminal-cancer. Accessed Sept 12, 2025.
  39. Cancer pain: Relief is possible. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/cancer-pain/art-20045118. Accessed Sept. 18, 2025.
  40. Health Education & Content Services. Chordoma overview. Mayo Clinic; 2025.
  41. Sahgal A, et al. Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: Preliminary outcomes. Neuro-Oncology. 2015; doi:10.1093/neuonc/nou347.
  42. Chhabra AM, et al. Proton therapy for spinal tumors: A consensus statement from the Particle Therapy Cooperative Group. International Journal of Radiation Oncology, Biology, Physics. 2024; doi:10.1016/j.ijrobp.2024.04.007.
  43. Maroufi SF, et al. Stereotactic radiosurgery in the management of skull base chordomas: A comprehensive systematic review and meta-analysis. Neurosurgical Focus. 2024; doi:10.3171/2024.2.FOCUS249.
  44. Ghaith, AK, et al. Impact of proton versus photon radiotherapy on overall survival in the management of spinal chordoma and mortality risk prediction: A nationwide analysis. Journal of Neuro-Oncology. 2025; doi:10.1007/s11060-025-05104-y.
  45. Myneni, S, et al. Exploring perspectives on skull base chordoma management: A modified Delphi approach to consensus. Journal of Neuro-Oncology. 2025; doi:10.1007/s11060-025-05088-9.
  46. Han Y, et al. Clinical differences among histological categories of sarcoma: Insights from 97,062 patients. Cancers (Basel). 2025; doi:10.3390/cancers17101706.
  47. Rodrigues ACLF, et al. Proton beam and carbon ion radiotherapy in skull base chordoma: A systematic review, meta-analysis and meta-regression with trial sequential analysis. Neurosurgical Review. 2024; doi:10.1007/s10143-024-03117-1.

相关

相关医疗程序

产品与服务

CON-20248515